サポート ブログ Antibody Isotypes: IgE

Antibody Isotypes: IgE

Biointron 2024-01-20 Read time: 3 mins
IgE.jpg
Adapted from DOI: 10.3390/antib8010019

Immunoglobulin E makes up the lowest serum concentration of all isotypes, but it is strongly potent, being associated with mediating hypersensitivity and allergic reactions, in addition to having roles in antiparasitic activity, autoimmune processes, and venom protection.

Since IgE is a monomer composed of two epsilon-heavy chains and light chains, it can only bind two antigens, but the structure of their heavy chain C-terminal regions is crucial for the binding to high-affinity cellular receptor Fc-epsilon R1 and low-affinity CD23.1

FcɛRI is expressed on mast cells, basophils, Langerhans cells, and eosinophils, with circulating IgE upregulating FcɛR expression on these cells. This expression and upregulation are what allows the highly potent IgE to be responsible for immediate hypersensitivity reactions, parasitic immunity, enhanced cytokine production, and antigen presentation. This ultimately results in cellular degranulation and the release of vasoactive and pro-inflammatory mediators.2,3 

On the other hand, CD23 is mainly expressed on B-cells, T-cells, and antigen-presenting cells, and manages IgE production homeostasis, facilitated antigen presentation, and IgE transportation through airway and gut epithelial cells.2

Recently, research into anti-IgE antibodies as therapy for allergy and asthma has been increasing, with antibodies being designed to target free IgE and membrane-bound IgE. As of now, the monoclonal antibody omalizumab is the only licensed anti-IgE therapy available for clinical use in allergic asthma and chronic spontaneous urticaria. Other drugs in development include ligelizumab, which demonstrates improvements to IgE binding, production and basophil activation compared to omalizumab. Furthermore, IgE antibody MOv18 has shown potential for cancer therapy.4

At Biointron, we are dedicated to accelerating your antibody discovery, optimization, and production needs. Our team of experts can provide customized solutions that meet your specific research needs. Contact us to learn more about our services and how we can help accelerate your research and drug development projects. 


References:

  1. Schroeder, H. W., & Cavacini, L. (2010). Structure and Function of Immunoglobulins. The Journal of Allergy and Clinical Immunology, 125(2 0 2), S41. https://doi.org/10.1016/J.JACI.2009.09.046

  2. Godwin, L., Sinawe, H., & Crane, J. S. (2022). Biochemistry, Immunoglobulin E. StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK541058/

  3. Gasser, P., Tarchevskaya, S. S., Guntern, P., Brigger, D., Ruppli, R., Zbären, N., Kleinboelting, S., Heusser, C., Jardetzky, T. S., & Eggel, A. (2020). The mechanistic and functional profile of the therapeutic anti-IgE antibody ligelizumab differs from omalizumab. Nature Communications 2020 11:1, 11(1), 1–14. https://doi.org/10.1038/s41467-019-13815-w

  4. Spicer, J., Basu, B., Montes, A., Banerji, U., Kristeleit, R., Miller, R., Veal, G. J., Corrigan, C. J., Till, S. J., Figini, M., Canevari, S., Barton, C., Jones, P., Mellor, S., Carroll, S., Selkirk, C., Nintos, G., Kwatra, V., Funingana, I. G., … Karagiannis, S. N. (2023). Safety and anti-tumour activity of the IgE antibody MOv18 in patients with advanced solid tumours expressing folate receptor-alpha: a phase I trial. Nature Communications 2023 14:1, 14(1), 1–11. https://doi.org/10.1038/s41467-023-39679-9

Subscribe to our ブログ

Recent ブログ

The therapeutic efficacy of antibodies is closely related to their ability to recognize and bind specific epitopes on target antigens. Epitopes, or antigenic determinants, are a group of amino acids or other chemical groups that are part of a molecule to which an antibody attaches itself. Epitope characterization can help reveal the mechanism of antibody binding and apply intellectual property (patent) protection for novel antibodies, in addition to designing antibodies with high specificity and minimal cross-reactivity.

Jul 12, 2024
ブログ

Understanding the differences between antibody specificity and selectivity is essential for designing and interpreting antibody-based assays in research for experimental accuracy and data interpretation. Antibody specificity refers to an antibody's ability to recognize and bind to a particular epitope—a unique part of an antigen that elicits an immune response.

Jul 10, 2024
ブログ

Antibody-based assays are essential tools in biomedical research, providing the means to detect, quantify, and visualize specific proteins or antigens within complex biological samples. These assays' efficacy hinges on the antibodies' precise properties. While affinity, avidity, specificity, and selectivity are fundamental to antibody performance, the ultimate impact of these properties is heavily influenced by the experimental context in which the antibody is employed.

Jul 08, 2024
ブログ

Biologics, particularly antibodies, have become indispensable in biomedical research and therapeutic development. Research-use-only (RUO) biologics play a pivotal role in preclinical studies, providing researchers with the necessary tools to explore antibody functions and therapeutic potential in vivo.

Jul 04, 2024
ブログ

お客様の利便性を向上させるためにクッキーを使用しています。詳しくは プライバシーポリシー をご覧ください。